Incidence and risk factors of retinopathy in patients with melanoma treated with high dose of interferon α-2b(HDI).

Di Wu,Shijie Lan,Zhihua Cui,Qiliang Yin,Lingling Liang,Hua He,Zhen Guo,Zhigang Liu,Hesong Liu,Xuan Wang,Yingying Yu,Wenqiu Zhang

Incidence and risk factors of retinopathy in patients with melanoma treated with high dose of interferon α-2b(HDI).

2018

Di Wu
Shijie Lan
Zhihua Cui
Qiliang Yin
Lingling Liang
Hua He
Zhen Guo
Zhigang Liu
Hesong Liu
Xuan Wang
Yingying Yu
Wenqiu Zhang

e21635Background: Retinopathy is one of the rare side effects of interferon α-2b. It has been observed in the treatment of hepatitis with low or middle dose interferon α-2b, but only a few cases ha...

Keywords:

Melanoma
Oncology
Retinopathy
Interferon α-2b
Pathology
Medicine
Internal medicine
Interferon
Gastroenterology
in patient
Hepatitis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations